L H Jensen Selected Research

Squamous Cell Carcinoma (Epidermoid Carcinoma)

1/2022

A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

L H Jensen Research Topics

Disease

5	Neoplasms (Cancer) 01/2022 - 09/2012
3	Colorectal Neoplasms (Colorectal Cancer) 03/2018 - 03/2010
2	Rectal Neoplasms (Rectal Cancer) 07/2010 - 03/2010
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	COVID-19 07/2021
1	Cholangiocarcinoma 05/2014
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 09/2012
1	Microsatellite Instability 09/2011
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2005
1	Poisoning 01/2000

Drug/Important Bio-Agent (IBA)

1	B7-H1 AntigenIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	PlatinumIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 03/2018
1	Urokinase Plasminogen Activator ReceptorsIBA 05/2014
1	Panitumumab (Vectibix)FDA Link 09/2012
1	Biomarkers (Surrogate Marker)IBA 09/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2011
1	Thymidylate SynthaseIBA 03/2010
1	XELOXIBA 03/2010
1	Capecitabine (Xeloda)FDA Link 03/2010
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2010
1	insulin aspart protamine drug combination 30:70 insulin aspartIBA 03/2005
1	4,4'- (1,2- dimethyl- 1,2- ethanediyl)bis- 2,6- piperazinedioneIBA 01/2000

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 01/2022 - 09/2012
2	Therapeutics 07/2021 - 09/2012
2	Radiotherapy 07/2010 - 03/2010
1	Combination Drug Therapy (Combination Chemotherapy) 09/2012